Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Regeneron Pharmaceuticals Inc (REGN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
877.500 +0.000    +0.00%
07/02 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Austria
ISIN:  US75886F1075 
  • Volume: 0
  • Bid/Ask: 861.500 / 877.500
  • Day's Range: 870.000 - 877.500
Regeneron Pharma 877.500 +0.000 +0.00%

REGN Ratios

 
Assess the performance of Regeneron Pharma (REGN). This table contains core financial ratios such as Price-to-Earnings (P/E ratio), Return-On-Investment (ROI), Earnings per share (EPS), Dividend yield and others based on Regeneron Pharmaceuticals Inc's latest financial reports. Compare the performance metrics of Regeneron Pharma (REGN) against the industry averages.
InvestingPro Advanced Ratios
Name Company Industry
   
P/E Ratio TTM 24.5 15.05
Price to Sales TTM 7.38 8.84
Price to Cash Flow MRQ 21.08 19.13
Price to Free Cash Flow TTM 24.99 17.55
Price to Book MRQ 3.73 4.85
Price to Tangible Book MRQ 4.04 4.68
   
Profitability: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Gross margin TTM 52.32% 42.47
Gross Margin 5YA 57.49% 17.52
Operating margin TTM 32.27% 20.46
Operating margin 5YA 41.74% -11.65
Pretax margin TTM 32.01% 22.87
Pretax margin 5YA 42.89% -12.47
Net Profit margin TTM 30.14% 17.9
Net Profit margin 5YA 38.7% -14.3
   
Revenue/Share TTM 123.34 65.88
Basic EPS ANN 37.05 18.38
Diluted EPS ANN 34.77 17.48
Book Value/Share MRQ 244.23 111.67
Tangible Book Value/Share MRQ 232.78 91.83
Cash/Share MRQ 25.67 25.89
Cash Flow/Share TTM 43.2 19.23
   
Management Effectiveness: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Return on Equity TTM 16.26% 12.49
Return on Equity 5YA 30.33% 21.68
Return on Assets TTM 12.69% 9.02
Return on Assets 5YA 21.85% 14.96
Return on Investment TTM 14.06% 10.69
Return on Investment 5YA 25.76% 18.18
   
EPS(MRQ) vs Qtr. 1 Yr. Ago MRQ -2.77% -38.16
EPS(TTM) vs TTM 1 Yr. Ago TTM -8.53% -8.86
5 Year EPS Growth 5YA 10.34% 9.14
Sales (MRQ) vs Qtr. 1 Yr. Ago MRQ 0.58% 8.6
Sales (TTM) vs TTM 1 Yr. Ago TTM 7.76% 19.37
5 Year Sales Growth 5YA 20.58% 36.66
5 Year Capital Spending Growth 5YA 13.41% 12.2
   
Quick Ratio MRQ 4.72 3.45
Current Ratio MRQ 5.69 3.59
LT Debt to Equity MRQ 7.63% 28.87
Total Debt to Equity MRQ 10.74% 32.34
Efficiency    
Asset Turnover TTM 0.42 0.42
Inventory Turnover TTM 2.51 4.89
Revenue/Employee TTM 975.26K 678.42K
Net Income/Employee TTM 293.95K -15.76K
Receivable Turnover TTM 2.83 4.76
   
Dividend Yield ANN - -
Dividend Yield 5 Year Avg. 5YA - -
Dividend Growth Rate ANN 0% -
Payout Ratio TTM - -
TTM = Trailing Twelve Months  5YA = 5-Year Average  MRQ = Most Recent Quarter
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced valuation and financial ratios for in-depth analysis of company financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

REGN Comments

Write your thoughts about Regeneron Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
양 한
양 한 Aug 24, 2023 10:16AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Scd411 is imminent
Avi Kalo
Avi Kalo Feb 03, 2023 9:03AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
REGN Earnings are wrong !!! it was 3.41B not M
borat smagadijev
borat smagadijev Jun 09, 2022 3:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Falling knife
Petet Larkar
Petet Larkar Jun 09, 2022 3:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I want your ******
Carmen Esparza
Carmen Esparza Jan 10, 2022 2:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Eliav Biton
Eliav Biton Nov 17, 2021 1:30AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
best opportunity in this market
Financial Advisors
Financial Advisors Nov 04, 2021 6:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
only take long positions .
David Lousada
David Lousada Nov 04, 2021 6:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
huge earnings beat!
Richard Senato
Richard Senato Sep 13, 2021 11:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Whats happening
Marut Patphol
Marut Patphol Sep 13, 2021 11:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Fall
ken ken
ken ken Sep 13, 2021 11:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Most of sales in this quarters are from COVID, and competion announced results
York Regent
York Regent Aug 05, 2021 9:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Acquiring Inovio will propel REGN closer to COVID 19 vaccine and clear path to 1K a share.
York Regent
York Regent Aug 05, 2021 9:43AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This should boost Inovio. Time to pile up.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email